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Objectives: Vascular calciﬁcation is a major clinical problem and elucidating the underlying mechanism
is important to improve the prognosis of patients with cardiovascular disease. We aimed to elucidate the
roleandmechanismofactionofHepatocyteGrowthFactor (HGF)/c-Met signalling invascular calciﬁcation
and establish whether blocking this pathway could prevent mineralisation of vascular smooth muscle
cells (VSMCs) in vitro.
Methods and results: We demonstrate increased HGF secretion and c-Met up-regulation and phos-
phorylation during VSMC osteogenic differentiation. Adenoviral-mediated over-expression of HGF
(AdHGF) in VSMCs accelerated mineralisation, shown by alizarin red staining, and signiﬁcantly increased
45Calcium incorporation (1.96±0.54-fold [P<0.05]) and alkaline phosphatase (ALP) activity (3.01±0.8-
fold [P<0.05]) compared to controls. AdHGF also signiﬁcantly elevated mRNA expression of bone-related
proteins, Runx2, osteocalcin, BMP2 and osterix in VSMCs. AdHGF-accelerated mineralisation correlated
with increased Akt phosphorylation, nuclear translocation of Notch3 intracellular domain (N3IC) and up-
regulation of the Notch3 target protein, HES1. In contrast, adenoviral-mediated over-expression of the
HGF antagonist, NK4, markedly attenuated VSMC mineralisation, and reduced c-Met phosphorylation,
Akt activation and HES1 protein expression compared to AdHGF-treated cells. Furthermore, the Notch
inhibitor, DAPT, attenuated N3IC nuclear translocation and AdHGF-induced mineralisation.
Conclusion: We demonstrate HGF induces VSMC osteogenic differentiation via c-Met/Akt/Notch3 sig-
nalling, highlighting these pathways as potential targets for intervention of vascular calciﬁcation.. Introduction
The presence of vascular calciﬁcation is a severe clinical
roblem, and is prognostic for an increased risk of adverse car-
iovascular outcomes [1]. It is now well-established that vascular
alciﬁcation results from transformation of vascular smooth mus-
le cells (VSMCs) into osteo/chondrocytic-like cells in response
o local micro-environmental cues, such as elevated calcium and
hosphate levels, oxidative stress and several cytokines [2]. How-
ver, methods to attenuate vascular calciﬁcation in vivo have not
et been elucidated.
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Hepatocyte growth factor (HGF) is a mesenchyme-derived
cytokine with multiple biological effects on a wide variety of cells
including mitogenic, motogenic, morphogenic, and anti-apoptotic
activities. It can be inhibited by NK4, which consists of the N-
terminal hairpin domain and the four kringle domains of the HGF
-chain [3,4]. Serum HGF has been linked with progression of
atherosclerosis [5], and localisedexpressionofHGFand its receptor,
c-Met, have been detected in atherosclerotic lesions [6]. HGF/c-
Met signalling can also promote osteogenic differentiation of bone
marrow stromal cells [7]. However, whether HGF/c-Met signalling
regulates the osteogenic differentiation of VSMCs is unknown.
HGF/c-Met signalling operates through many downstream tar-
gets, including PI3K/AKT and Notch in myocardium [8]. The
Notch family comprises four transmembrane receptor proteins
Open access under CC BY license.(Notch 1–4). Cleavage of the receptor leads to release and
nuclear translocation of the intracellular domain (NICD), activating
downstream target genes, which play important roles in vascu-
lerosis
l
a
o
m
e
e
s
H
c
m
p
N
t
B
b
i
c
2
2
c
f
i
p
t
g
m
p
i
a
a
2
(
d
a
o
2
a
f
w
I
i
2
b
t
b
(
T
1
mY. Liu et al. / Atherosc
ar development [9]. Recently, Notch1 was detected in calciﬁed
therosclerotic plaque, but not in normal vessels [10]. Furthermore,
ver-expression of Notch1 NICD signiﬁcantly increased matrix
ineralisation in human aortic SMCs [10]. Although Notch3 is
xpressed in human adult smooth muscle cells [11], neither its
xpression in calciﬁc lesions, nor its role in VSMC osteogenic tran-
ition have been studied.
This study shows for the ﬁrst time that activation of
GF/c-Met signalling accelerates VSMC mineralisation, a pro-
ess attenuated by the HGF antagonist NK4. HGF-accelerated
ineralisation of VSMCs in vitro occurs with concomitant phos-
horylation of Akt, activation of Notch3 and up-regulation of the
otch3 target transcription factor HES1. Finally, we demonstrate
hat N-[N-(3,5-Diﬂuorophenacetyl-Lalanyl)]-S-phenylglycine t-
utyl Ester (DAPT), an inhibitor of Notch signalling, attenuates
oth mineralisation and AdHGF-accelerated VSMC mineralisation
n vitro, supporting links between Notch signalling and vascular
alciﬁcation.
. Materials and methods
Further details are provided in the online supplement.
.1. Tissue collection and human vascular smooth muscle cell
ulture
Approval fromtheLocalResearchEthicsCommitteewasgranted
or human tissue use, and procedures were in accordance with
nstitutional guidelines. The investigation also conforms with the
rinciples outlined in the Declaration of Helsinki. VSMC explanta-
ion was carried out as previously described [12], and the age and
ender of the donors are listed in supplementary Table 1. Experi-
ents were performed with three individual cell populations, thus
roviding biological triplicates. Human tibial VSMCs were cultured
n SMC growth media (PromoCell) and used between passages 4
nd 7. See online supplement for detailed culture conditions and
denoviral transduction.
.2. Induction and determination of calciﬁcation
Mineralisation of VSMCs was induced using osteogenic media
see online supplement) Protocols for determining osteogenic
ifferentiation and calciﬁcation, i.e. alkaline phosphatase assay,
lizarin red staining and the calcium assay are described in the
nline supplement.
.3. Hepatocyte growth factor enzyme-linked immunosorbent
ssay
The concentration of HGF in 48h-conditioned media (50l)
rom conﬂuent VSMCs grown in regular or osteogenic media
as determined at speciﬁc time-points by ELISA (Quantikine HGF
mmunoassay kit, R&D Systems), according to the manufacturer’s
nstructions.
.4. Quantitative RT-PCR
RNA was isolated from cells using TRIZOL (Invitrogen), followed
y cDNA synthesis using Mu-MLV reverse transcriptase (Eurogen-
ec). Quantitative PCR was performed in quadruplicate samples
y a StepOne PCR system (Applied Biosystems) with SYBR Green
Eurogentec). Primers were purchased from Qiagen (supplement
able 2). Expression levels of target genes were corrected using
8S and calculated with the comparative cycle threshold (CT)
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2.5. Western blot and immunoprecipitation analysis
Primary antibodies were used in western blotting to detect
expression of HGF (sc-7949, 1:500), c-Met (sc-161, 1:500), Notch3
intracellular domain (M-134, 1:1000), HES1 (sc-25392, 1:1000),
and -tubulin (sc-5274, 1:500) (Santa Cruz); phosphorylated Akt
(no.9271, 1:1000) and total Akt (no.9272, 1:1000) (Cell Signalling
Technology Inc); osteoprotegerin (MAB8051, 1:500) (R&D Sys-
tems). The phosphorylation status of c-Met was analysed by
immunoprecipitation and immunoblotting. See online supplement
for further details.
2.6. Immunoﬂuorescence
Cells were incubated with an antibody against the intracellular
domain of Notch3 (M-134) followed by Alexa Fluor 488 anti-rabbit
IgG (A11034, Invitrogen). Rabbit IgG was the negative control.
Nuclei were counterstained with DAPI.
2.7. Statistical analysis
Data shown are representative of at least 3 independent experi-
ments using cells from three different patients. Data are expressed
as mean± SD. Differences between groups were analysed with a
Student’s t test or ANOVA. P<0.05 was considered statistically sig-
niﬁcant.
3. Results
3.1. HGF/c-Met signalling is activated in VSMCs undergoing
osteogenesis
Aspreviously reported [13],when conﬂuentVSMCs are cultured
in the presence of -glycerophosphate (-GP, 5mmol/L) and ele-
vated calcium (2.6mmol/L) (osteogenic media), a calciﬁed matrix
is deposited, which stains positivewith alizarin red. Nomineralisa-
tion is detected in VSMCs cultured with regular growth media for
21 days (supplement Fig. 1).
To determine whether HGF expression is modulated dur-
ing osteogenic differentiation of VSMCs, the level of HGF in
VSMC conditioned medium was measured using an ELISA.
HGF concentrations in conditioned media from cells cul-
tured in regular growth media was 1154.6±19.3pg/ml,
1581.4±65.1pg/ml, 1099.2±36.2pg/ml, 884.6±361.7pg/ml,
1040.1±258.7pg/ml, respectively, at day 2, 5, 7, 14, and 21. Signif-
icantly increased HGF levels were detected in VSMCs cultured in
osteogenic media (2468.7±156.7pg/ml, 2324.0.6±436.4pg/ml,
2509.7±453.3pg/ml, 3871.7±416.9pg/ml) on days 5, 7, 14, and
21, respectively (Fig. 1A). There was no signiﬁcant difference
between regular and osteogenic media on day 2.
The expression and activation of c-Met in VSMCs cultured in
regular or osteogenic media were also determined. Western blot
analysis demonstrated an increase in c-Met expression (3.0±0.6-
fold, P<0.01) and phosphorylation (1.5±0.2-fold, P<0.05) as early
as day 2 in VSMCs cultured in osteogenic media, compared to cells
in regularmedia (Fig. 1B). However, this increasewas not sustained
andbyday21, c-Metexpressionandphosphorylationwas similar in
cells grown in both regular and osteogenicmedia.-Tubulin shows
protein loading.
3.2. AdHGF accelerates VSMC osteogenic differentiationTo investigate the effects of activated HGF/c-Met signalling on
VSMC mineralisation, recombinant adenovirus was used to over-
express HGF in VSMCs in vitro; AdEGFP was used as a control.
More than 80% of VSMCs were infected without evidence of cell
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Fig. 1. (A) ELISA showingHGF levels in conditionedmedium fromSMCsgrown inosteogenic or regularmedia at speciﬁc time-points. *P<0.05, osteogenic vs normal conditions
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ultured in osteogenic and regular media.
oxicity (supplement Fig. 2). When VSMCs were maintained in
egular growth media for 21 days, marked aggregation and retrac-
ion of HGF-over-expressing cells was noted (Fig. 2A, arrows). In
ontrast, this effect was absent in cells transduced with control
dEGFP virus (Fig. 2A) or non-infected controls (not shown). Fur-
hermore, AdHGF-infected VSMCs, cultured in osteogenic media
or 8 days showed accelerated matrix mineralisation; no mineral
as detected in control AdEGFP-infected VSMC at this time-point
Fig. 2B).
Mineralisation was quantiﬁed by determining levels of 45Ca
ncorporation into the cell layer. The results (Fig. 2C) demon-
trate calcium incorporation was signiﬁcantly enhanced at day
(1.96±0.55-fold, P<0.05) in cells over-expressing HGF, com-
ared to controls. ALP activity, (an early marker of osteogenic
ifferentiation) was also increased 3.01±0.80-fold (P<0.05) in
dHGF-infected VSMCs compared to AdEGFP-infected controls
fter 8 days in culture (Fig. 2D). Furthermore, HGF over-expression
igniﬁcantly up-regulated mRNA levels of bone-related proteins,
amely Runx2, ALP, Osteocalcin (OC), BMP2, and Osterix (Fig. 2E).
ext, VSMCs were infected with AdNK4 to inhibit endogenous
GF/c-Met signalling and alizarin red staining demonstrates ad densitometry analysis showing c-Met expression and phosphorylation in SMCs
marked attenuation of mineralisation in NK4-infected cells, vs
AdEGFP-infected control cells grown in osteogenic media for 21
days (Fig. 2F).
3.3. Over-expression of HGF activates Akt phosphorylation in
VSMCs
Since regulation and execution of HGF signalling is dependent
on phosphorylation of c-Met, this was investigated in VSMCs after
AdHGF-, AdNK4- and AdEGFP-infection (Fig. 3Ai & ii) and quanti-
ﬁed by densitometry using -tubulin as a protein loading control
(Fig. 3B). Two days after infection, no change in c-Met expression
wasapparent (Fig. 3Ai&Bi)whilst a1.7±0.3-fold (P<0.01) increase
in c-Met phosphorylation was detected in HGF-over-expressing
cells compared to controls (Fig. 3Aii & Bii). Of note, c-Met phospho-
rylation was reduced in NK4-over-expressing cells (0.5±0.2-fold,
P<0.05) compared to control-infected cells (Fig. 3A and B). On
day 8, c-Met expression and phosphorylation were comparable
in all samples (supplement Fig. 3A and B). HGF over-expression
also reduced the expression of the calciﬁcation inhibitor,
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Fig. 2. (A) VSMCs infected with AdEGFP or AdHGF and cultured in regular media for 21 days showed different growth patterns. (B) Alizarin red staining shows accelerated
VSMC mineralisation in osteogenic media at day 8 in AdHGF-infected SMCs vs. AdEGFP-infected SMCs. Bar =200m. (C) 45Ca accumulation and (D) ALP activity in VSMCs
infected with AdEGFP and AdHGF and grown in osteogenic media. (n=3) *P<0.05 AdEGFP vs AdHGF-infected cells. #P<0.005 day 2 vs. day 8. (E) Expression of bone-related
genes evaluated 2 days after infection by quantitative PCR. (n=4) *P<0.05 AdEGFP vs AdHGF. (F) Representative photomicrographs of AdNK4-infected and control VSMCs
cultured in osteogenic media for 21 days (Control) and stained with Alizarin red shows VSMC mineralisation was attenuated in AdNK4-infected cells compared to controls.
Bar =200m.
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Ai). In contrast, NK4 over-expression down-regulated c-Met phosphorylation (Aii &
ells, compared to AdEGFP-infected cells (Aii & Biii). (C) Over-expression of HGF up
steoprotegerin (OPG), whereas AdNK4 up-regulated OPG expres-
ion (2.0±0.6-fold, P<0.05).
PI3K/Akt signalling is activated by phospho-c-Met [14]. There-
ore, we examined Akt phosphorylation in VSMC infected with
dHGF, AdNK4 or control virus and cultured in osteogenic media.
ver-expression of HGF markedly induced Akt phosphorylation at
ay 2 (65±35-fold, P<0.01), and although AdNK4 over-expression
n VSMCs for 2 days showed elevated Akt phosphorylation com-
ared to control cells, it was markedly reduced compared to
ells induced to over-express HGF (Fig. 3C & D). By day 8,
hen AdHGF-infected VSMCs deposited a mineralised matrix,
kt phosphorylation was still elevated (20.5±14.5-fold, P<0.01),
lthough itwas reduced compared to 2 days following infection. No
etectable Akt phosphorylation was observed in VSMCs infected
ith control virus (Fig. 3C & D). Low levels of Akt phosphorylation
ere still apparent in VSMCs 8 days after infection with AdNK4.gniﬁcantly increased phosphorylation of c-Met, but little effect on c-Met expression
PG expression was reduced in AdHGF-infected cells but increased in NK4-infected
ated phosphorylation of Akt at days 2 and 8 (*P<0.01, #P<0.05, n=3).
3.4. Over-expression of HGF activates notch3 signalling
Notch3 is expressed inhumanadult smoothmuscle cells [14,15],
but its role in VSMC osteogenic differentiation has not been
investigated. Therefore, we interrogated Notch3 signalling dur-
ing HGF-induced osteogenic differentiation of VSMCs. Notch3 was
detected in both the cytoplasm and nuclei in control VSMCs grown
in osteogenic media at day 2 (Fig. 4A), and in cells infected with
AdBgl, an empty control virus (data not shown), indicating a low
level of basal Notch3 activation in VSMCs.
However, 8 days after AdHGF infection of VSMCs, Notch3 was
mainly localised in the nuclei, suggesting HGF over-expression
triggers Notch3 activation (Fig. 4B). Validation of HGF-activation
of Notch-3 comes from the ﬁnding that a signiﬁcant increase in
expression of the Notch3 downstream target protein HES1 was
apparent 8 days after HGF over-expression (36±8-fold, P<0.01),
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Fig. 4. Representative micrographs show localisation of active Notch3 in SMCs infected with control AdEGFP (A) or AdHGF (B). (C) Western blotting show HES1 expression
and -tubulin expression as a loading control. *P<0.01. (D) Localisation of Notch3 in VSMCs infected with AdHGF in the presence or absence of DAPT (1mol/L). (E) Alizarin
r edia
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ted staining showed DAPT reduced mineralisation in VSMC cultured in osteogenic m
or 8 days (n=3). Bar in A & B=100m; D=25m, E & F=200m.hilst AdNK4 had an insigniﬁcant effect on HES1 expression
Fig. 4C). It is noteworthy that neither the Notch3 nuclear translo-
ation nor the HES1 upregulation was observed after 2 days
reatment, unlike the dramatic activation of PI3K/Akt signalling,for 21 days and (F) in SMCs infected with AdHGF and cultured in osteogenic mediasuggesting thatNotch3 signallingmight act as a downstream target
of the HGF/c-Met-PI3K/Akt axis.
Next, AdHGF-infected with VSMCs were treated with
DAPT, a -secretase inhibitor that prevents N3IC release. We
446 Y. Liu et al. / Atherosclerosis
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Fig. 5. Model showing elevated calcium and/or phosphate up-regulate HGF secre-
tion and c-Met activation in conjunction with activation of the PI3K/Akt signalling
pathway, leading to SMC mineralisation, which can be inhibited by AdNK4 treat-
ment. Signalling molecules and osteogenic transcription factors downstream of
PI3K/Akt were shown to be involved in HGF/c-Met-induced mineralisation. We also
show HGF/c-Met-induced Notch3 activation and using the Notch inhibitor, DAPT,
we demonstrate attenuation of calciﬁcation suggesting Notch3 signalling involve-
m
i
a
d
c
o
V
p
t
m
e
N
d
4
w
r
t
p
v
t
s
(
l
p
g
e
t
p
a
t
Hent in this process. The dotted arrowsbetween c-Met activation andHGF secretion
ndicate other factors could be associatedwith c-Met receptor andHGF ligand inter-
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emonstrate that DAPT attenuates HGF-induced nuclear translo-
ation of Notch3 (Fig. 4D). To establish whether DAPT-inhibition
f Notch signalling would also modulate mineral deposition by
SMCs, cells were cultured in osteogenic media for 21 days in the
resence or absence of DAPT. Alizarin red staining demonstrates
hat inhibition of Notch signalling by DAPT markedly attenuated
ineral deposition by VSMCs (Fig. 4E). AdHGF-accelerated min-
ralisation was also reduced by DAPT (Fig. 4F), suggesting that
otch signalling is essential for HGF-induced VSMC osteogenic
ifferentiation.
. Discussion
In the vasculature, HGF/c-Met signalling has been associated
ith endothelial dysfunction and angiogenesis [16], and more
ecently with atherosclerosis [6,17]. We demonstrate that activa-
ion of HGF/c-Met signalling could be an early response to certain
athological stimuli, such as elevated Ca and P, which triggers
ascular calciﬁcation, thereby inducing VSMC osteogenic differen-
iation via activation of Akt and Notch3 signalling in vitro. We also
how potential for inhibition of this process by either NK4 or DAPT
Fig. 5).
We demonstrate increased c-Met expression and phosphory-
ation in VSMCs 2 days after culture in osteogenic medium, which
recedes the up-regulation of HGF secretion detected at day 5, sug-
esting that, under these conditions, a positive autocrine loop may
xist between c-Met activation and HGF expression. It is possible
hat the c-Met receptor is up-regulated by the elevated calcium or
hosphate conditions in the osteogenic media, thus leading to the
pparent increased c-Met phosphorylation and immediate activa-
ion of Akt, with Notch3 activation at a later time-point. Elevated
GF expression also activated c-Met-PI3K/Akt-Notch3 signalling in219 (2011) 440–447
VSMCs. Our results showed thatHES1 expressionwas up-regulated
8 days after HGF over-expression, whereas HGF-induced c-Met
activation was comparable to the control group at this time-point,
suggesting thatHGF/c-Met signalling could be negatively regulated
by Notch3/HES1 in VSMCs; a ﬁnding consistent with a previous
study showing negative feedback betweenHES1 and c-Met expres-
sion [18].
Previous reports have suggested that mesenchymal stem cells
grow and organise into distinct patterns when they undergo
osteogenic differentiation in vitro [19]. The present study demon-
strates that VSMCs infected with AdHGF, aggregated together
and retracted away from each other. In osteogenic conditions,
AdHGF up-regulated mRNA levels of several bone-related proteins,
namely, Runx2, ALP, OC, and BMP2. BMP2 is a potent inducer
and morphogen in the process of SMC osteogenic differentiation.
Therefore, our results indicate that HGF may either act as a novel
morphogen in the early differentiation process of VSMCs or may
facilitate VSMC differentiation via the BMP2 pathway. This sugges-
tion is in accordance with Hossain et al. [7] who demonstrated that
HGF enhancesMC3T3-E1 pre-osteoblast differentiation by increas-
ing Runx2, ALP, and OC mRNA expression. In addition, D’Ippolito
et al. [20] demonstrated thatwhenHGFwas coupledwithvitaminD
treatment, it signiﬁcantly increasedALPexpression inbonemarrow
stromal cells, but mineralisation was only detected in the pres-
ence of HGF and 1,25-didroxy Vitamin D3 and not in the presence
of HGF alone. Despite the fact that cultured VSMCs may undergo
certain phenotypic changes in vitro, this is still a well-established
in vitro model of vascular calciﬁcation. Therefore, the results from
Hossain et al. [7] and D’Ippolito et al. [20], taken together with
our studies demonstrating (i) mineralisation is induced by HGF
only in the presence of high calcium and phosphate and not in
regular growth media, and (ii) that mineralisation can be attenu-
ated by AdNK4, suggest that under speciﬁc micro-environmental
conditions, such as hypercalcemia or hyperphosphatemia, HGF
could play an important role at several stages of vascular
calciﬁcation.
Since c-Met is a transmembrane receptor tyrosine kinase,
downstream events following HGF/c-Met binding were investi-
gated. We show that Akt phosphorylation was increased at the
2-day time-point following HGF-over-expression and less so by
NK4. Akt phosphorylation was undetectable in VSMCs infected
with control virus and cultured in osteogenic conditions for 8
days, suggesting that early activation of Akt signalling may be
involved in HGF-induced osteogenic differentiation of SMCs in
vitro, and there is a possible positive-feedback between HGF and
c-Met. The data from our study support previous studies which
also show Akt activation during BMP-2-induced osteoblast dif-
ferentiation of 2T3 cells [21], and also in bone development
[22].
In vivo studies have shown that Notch3−/− vessels lose their
arterial phenotype, indicating that Notch3 is crucial for SMC phe-
notypic differentiation [23]. Since we have shown attenuation of
mineralisation by both NK4 and DAPT, we speculate that HGF/c-
Met-Notch3 axis could play an important role in the development
of vascular calciﬁcation. Our data showing HGF/c-Met/Notch3
signalling in VSMCs support and extend the ﬁndings that NICD-
expressing human mesenchymal stem cells undergo enhanced
osteogenic differentiation [24], and also that HGF-treatment of car-
diomyocytes up-regulates the Notch effector HES1 via PI3K/Akt
signalling[8], suggesting an outside-in signal transduction cascade
extending from HGF/c-Met to Notch.
In summary, this is the ﬁrst report demonstrating that HGF/c-
Met-PI3K/Akt-Notch3 signalling can regulate vascular calciﬁcation.
Future studies using animal models will generate data that could
have implications for the development of new targets for potential
therapeutic intervention of this devastating pathology.
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